Gene profiling in human blood leucocytes during recovery from septic shock

Intensive Care Med. 2008 Aug;34(8):1371-6. doi: 10.1007/s00134-008-1048-1. Epub 2008 Apr 5.

Abstract

Objective: To assess blood leucocytes gene profiling during recovery phase of septic shock; to test the relation between encoding gene expression and protein level.

Study design: Gene expression levels were studied at days 0, 1, 7 and 28 (D0, 1, 7 and 28) on a dedicated microarray of 340 genes involved in inflammatory processes.

Settings: 16-bed intensive care unit, Lariboisière University hospital.

Patients: Seventeen septic shock patients enrolled when at least one additional organ dysfunction occurred.

Measurements and results: Changes over time were compared with D0 via the ratio Dx/D0. The time-related gene expression study showed significant changes in ten genes. Among them, S100A8 and S100A12 had a reduced expression over time compared with D0, whereas CD74's expression increased. The microarray results were validated by RT-qPCR for four genes. The S100A8 plasma levels decrease along recovery in parallel with the gene expression decrease. The CD74 gene expression evolution significantly correlated with HLA-DR monocyte expression.

Conclusions: These results are the first description of variations in expression of key inflammatory genes in the course of the septic shock recovery period.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, Differentiation, B-Lymphocyte / genetics
  • Calgranulin A / blood*
  • Calgranulin A / genetics
  • Calgranulin A / physiology
  • Gene Expression Profiling*
  • HLA-DR Antigens / genetics
  • HLA-DRB1 Chains
  • Histocompatibility Antigens Class II / genetics
  • Humans
  • Leukocytes
  • Middle Aged
  • Oligonucleotide Array Sequence Analysis / methods*
  • Reverse Transcriptase Polymerase Chain Reaction
  • Shock, Septic / genetics*
  • Shock, Septic / mortality
  • Survival Analysis

Substances

  • Antigens, Differentiation, B-Lymphocyte
  • Calgranulin A
  • HLA-DR Antigens
  • HLA-DRB1 Chains
  • HLA-DRB1*12:01:01 antigen
  • Histocompatibility Antigens Class II
  • invariant chain